Wikidata

(Q63574106)

English

DETERMINE-preserved - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Preserved Ejection Fraction

clinical trial

In more languages

Statements

title
International, Multicentre, Parallel-group, Randomised, Double-blind, Placebo-controlled, Phase III Study Evaluating the Effect of Dapagliflozin on Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction (English)
0 references
sponsor
AstraZeneca
0 references
country
Argentina
0 references
Brazil
0 references
Bulgaria
0 references
Canada
0 references
Denmark
0 references
Italy
0 references
Japan
0 references
Slovakia
0 references
South Africa
0 references
Sweden
0 references
start time
4 April 2019
0 references
end time
20 February 2020
0 references
number of participants
400
0 references
minimum age
40 year
0 references
maximum age
150 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63574106&oldid=1857264347"